Table 2. Results of Moderator Analyses for the Prevalence of Depressive Symptoms in Children and Adolescence During COVID-19.
Categorical moderators | No. of studies | Prevalence (95% CI) | Homogeneity Q | P value |
---|---|---|---|---|
Study quality scorea | ||||
2-3 | 21a | 0.27 (0.23-0.32)b | 3.64 | .06 |
4 | 5 | 0.18 (0.11-0.26)b | ||
Symptom reporter | ||||
Self-report | 23 | 0.25 (0.208-0.30)b | 0.06 | .80 |
Parent report | 3 | 0.27 (0.16-0.42)c | ||
Geographical region | ||||
East Asia | 16 | 0.22 (0.17-0.28)b | 2.83 | .24 |
North America | 5 | 0.28 (0.19-0.41)d | ||
Europe | 3 | 0.34 (0.20-0.51) | ||
Continuous moderators | No. of studies | Estimate (95% CI) | z | P value |
Participant | ||||
Age | 26 | 0.08 (0.01-0.15) | 2.10 | .04 |
Sex | 26 | 0.03 (0.01-0.05) | 3.03 | .002 |
Month of data collection in 2020 | 23 | 0.26 (0.06-0.46) | 2.54 | .01 |
Two studies had a study quality of 2 and were combined with those with a study quality of 3.
P < .001.
P = .01.